Document is current
Any future updates will be listed below
-
Authors
Worboys, Jonathan D. http://orcid.org/0000-0002-8242-4901
Vowell, Katherine N.
Hare, Roseanna K. http://orcid.org/0000-0001-8974-2489
Ambrose, Ashley R. http://orcid.org/0000-0002-0639-0690
Bertuzzi, Margherita http://orcid.org/0000-0002-5900-591X
Conner, Michael A.
Patel, Florence P.
Zammit, William H. http://orcid.org/0000-0001-9104-2078
Gali-Moya, Judit
Hazime, Khodor S. http://orcid.org/0000-0001-5125-2011
Jones, Katherine L.
Rey, Camille
Jonjic, Stipan http://orcid.org/0000-0001-5003-3108
Rovis, Tihana Lenac
Tannahill, Gillian M.
Cruz De Matos, Gabriela Dos Santos
Waight, Jeremy D.
Davis, Daniel M. http://orcid.org/0000-0002-9182-291X
-
Funding
Funding for this research was provided by:
Wellcome Trust (110091/Z/15/Z)
GlaxoSmithKline
RCUK | Medical Research Council (MR/W031698/1)
- License Information
-
More Information
Article History
Received: 23 December 2022
Accepted: 9 August 2023
First Online: 18 August 2023
Competing interests
: F.P.P., G.D.S.C.D.M., G.M.T., J.D.Waight, K.N.V. and M.A.C. are employed by GSK and DMD is a consultant and advisor to GSK. The remaining authors declare no competing interests.
